Literature DB >> 1212415

A test of several parametic statistical models for estimating success rate in the treatment of carcinoma cervix uteri.

R F Mould, J W Boag.   

Abstract

The parametric statistical models discussed include all those which have previously been described in the literature (Boag, 1948-lognormal; Berkson and Gage, 1952-negative exponential; Haybittle, 1959-extrapolated actuarial) and the basic data used to test the models comprised some 3000 case histories of patients treated between 1945 and 1962. The histories were followed up during the period treated between 1945 and 1962. The histories were followed up during the period 1969-71 and thus provided adequate information to validate long-term survival fractions predicted using short-term follow-up data. The results with the log-normal model showed that for series of staged carcinoma cervix patients treated during a 5-year period, satisfactory estimates of long-term survival fractions could be predicted after a minimum waiting period of 3 years for stages I and II, and 2 years for stage III. The model should be used with a value assumed for the lognormal paramater S in the range S = 0.35 to S = 0.40. Although alternative models often gave adequate predictions, the lognormal proved to be the most consistent model. This model may therefore now be used with more confidence for prospective studies on carcinoma cervix series and can provide good estimates of long-term survival fractions several years earlier than would otherwise be possible.

Entities:  

Mesh:

Year:  1975        PMID: 1212415      PMCID: PMC2024799          DOI: 10.1038/bjc.1975.259

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  4 in total

1.  Maximum utilization of the life table method in analyzing survival.

Authors:  S J CUTLER; F EDERER
Journal:  J Chronic Dis       Date:  1958-12

2.  The estimation of the proportion of patients cured after treatment for cancer of the breast.

Authors:  J L HAYBITTLE
Journal:  Br J Radiol       Date:  1959-11       Impact factor: 3.039

3.  The early estimation of the results of treatment for cancer.

Authors:  J L HAYBITTLE
Journal:  Br J Radiol       Date:  1960-08       Impact factor: 3.039

4.  Carcinoma of the vulva. Cure after operative therapy evaluated in accordance with Boag's statistical method.

Authors:  F Ronnike
Journal:  Dan Med Bull       Date:  1968-12
  4 in total
  14 in total

1.  Cancer statistics.

Authors:  R F Mould
Journal:  Br Med J       Date:  1976-01-10

2.  Multimodality therapy for locoregional extrahepatic cholangiocarcinoma: a population-based analysis.

Authors:  Clifton D Fuller; Samuel J Wang; Mehee Choi; Brian G Czito; John Cornell; Tania M Welzel; Katherine A McGlynn; Join Y Luh; Charles R Thomas
Journal:  Cancer       Date:  2009-11-15       Impact factor: 6.860

3.  A statistical model for cancer host survival.

Authors:  A Dunne; I A Kinsella
Journal:  Ir J Med Sci       Date:  1979-12       Impact factor: 1.568

4.  The biology of haematogenous metastasis in human uveal malignant melanoma.

Authors:  I W McLean
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

5.  Short- and long-term cause-specific survival of patients with inflammatory breast cancer.

Authors:  Patricia Tai; Edward Yu; Ross Shiels; Juan Pacella; Kurian Jones; Evgeny Sadikov; Shazia Mahmood
Journal:  BMC Cancer       Date:  2005-10-22       Impact factor: 4.430

6.  On the utility of the lognormal model for analysis of breast cancer survival in Sweden 1961-1973.

Authors:  L E Rutqvist
Journal:  Br J Cancer       Date:  1985-12       Impact factor: 7.640

7.  A model of long-term survival following adjuvant therapy for stage 2 breast cancer.

Authors:  J W Gamel; R L Vogel
Journal:  Br J Cancer       Date:  1993-12       Impact factor: 7.640

8.  Squamous carcinoma of the head and neck: cured fraction and median survival time as functions of age, sex, histologic type, and node status.

Authors:  J W Gamel; A S Jones
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

9.  Assessing the impact of adjuvant therapy on cure rate for stage 2 breast carcinoma.

Authors:  J W Gamel; R L Vogel; I W McLean
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

10.  Cervical cancer: Age at registration and age at death.

Authors:  R R West
Journal:  Br J Cancer       Date:  1977-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.